Balanced news tone
News Sentiment
BKHA sentiment intelligence
Black Hawk Acquisition Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
94/100 classification confidence.
directly relevant articles
high-authority source matches
+1.3% over one week, -0.2% over four weeks, trend active, and near fair-value range.
Black Hawk Acquisition Corporation (NASDAQ: BKHA) details Vesicor merger path, Nasdaq risk
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Black Hawk Acquisition Corporation (NASDAQ: BKHA) details Vesicor merger path, Nasdaq risk
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 15 Jul 2026 20:20
- Source
- Stock Titan
Black Hawk Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2026
Black Hawk Acquisition Corporation announced its earnings results for the second quarter and six months ended May 31, 2026. For the second quarter, the company reported a net income of USD 0.088929 million, a decrease from USD 0.520542 million in the prior year. Over the six-mont
- Tone
- Negative 18/100
- Event
- Deals and strategy
- Published
- 15 Jul 2026 20:21
- Source
- www.marketscreener.com
Black Hawk Acquisition Corporation (BKHA) Holds Steady at $11.96 – SPAC Premium Persists - Float Adjusted Cap
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Jul 2026 13:33
- Source
- dars.gov.et
Ukraine eyes UH-60 Black Hawks to replace aging Mi-8 fleet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- The Defence Blog
Black Hawk (BKHA) to domesticate, merge with Vesicor; $70M equity value condition
Black Hawk Acquisition Corporation (BKHA) is seeking shareholder approval to domesticate to Delaware and merge with Vesicor Therapeutics, Inc. The proposed business combination values Vesicor at an equity value of $70 million, with the combined entity planning to list on Nasdaq u
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 20:15
- Source
- Stock Titan
Sponsor funds Black Hawk (BKHA) with $300K 10% convertible note
Black Hawk Acquisition Corporation (BKHA) has secured a convertible promissory note of up to $300,000 from its sponsor, Black Hawk Management LLC, to provide working capital. The note carries a 10% annual interest rate, starting April 20, 2026, and is due upon a DeSPAC business c
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 May 2026 20:38
- Source
- Stock Titan
Black Hawk Acquisition Corporation announced that it expects to receive $0.3 million in funding from Black Hawk Management LLC
Black Hawk Acquisition Corporation announced it expects to receive $0.3 million in funding from Black Hawk Management LLC through a private placement of a convertible promissory note. The note, valued at $300,000, bears 10% interest per annum and is convertible into common shares
- Tone
- Positive 59/100
- Event
- Deals and strategy
- Published
- 05 May 2026 12:08
- Source
- www.marketscreener.com
BKHA SEC Filings - Black Hawk Acquisition Corp 10-K, 10-Q, 8-K Forms
This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 May 2026 07:39
- Source
- Stock Titan
Black Hawk Acquisition Corporation 10-K/A Filing: Corporate Certifications, Governance, and Compliance Details
Black Hawk Acquisition Corporation filed an amendment to its annual report (Form 10-K/A) solely to include its Compensation Recovery (Clawback) Policy, omitted from the original filing. This update, a compliance action based on SEC and Nasdaq directives, strengthens corporate gov
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 28 Apr 2026 22:39
- Source
- Minichart
Clawback policy added in Black Hawk Acquisition (NASDAQ: BKHA) 10-K/A
Black Hawk Acquisition Corporation (NASDAQ: BKHA) has filed an amendment (10-K/A) to its annual report for the fiscal year ended November 30, 2025. The sole purpose of this amendment is to include the company's Incentive Compensation Recovery (Clawback) Policy as Exhibit 97.1, wh
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 28 Apr 2026 20:39
- Source
- Stock Titan
Black Hawk Acquisition Corporation Reports Earnings Results for the First Quarter Ended February 28, 2026
Black Hawk Acquisition Corporation announced its earnings results for the first quarter ended February 28, 2026. The company reported a net income of USD 0.139805 million for the quarter, a decrease compared to USD 0.658379 million in the same period last year. Black Hawk Acquisi
- Tone
- Negative 29/100
- Event
- Deals and strategy
- Published
- 21 Apr 2026 11:39
- Source
- www.marketscreener.com
Black Hawk Acquisition 10-Q: Revenue $0.21M, EPS $0.03
Black Hawk Acquisition reported $0.213 million in revenue, primarily from interest income from its Trust Account, resulting in a net income of $139,805 and basic/diluted EPS of $0.03. Despite an operating loss of $54,189, non-operating interest income boosted overall profitabilit
- Tone
- Positive 61/100
- Event
- Deals and strategy
- Published
- 21 Apr 2026 10:39
- Source
- TradingView
Redemptions, Vesicor deal and Nasdaq notice shape Black Hawk (BKHA) outlook
Black Hawk Acquisition Corporation (BKHA) reported Q1 2026 unaudited results, showing $139,805 net income primarily from trust account interest, as it continues efforts to merge with Vesicor Therapeutics. The SPAC faces significant challenges, including substantial shareholder re
- Tone
- Negative 19/100
- Event
- Deals and strategy
- Published
- 20 Apr 2026 22:39
- Source
- Stock Titan
Black Hawk Acquisition Delays Quarterly SEC Filing
Black Hawk Acquisition Corporation (BKHA) has announced a delay in filing its Form 10-Q for the quarter ended February 28, 2026, due to needing additional time to finalize financial statements. The company expects to submit the report within a five-day extension period and does n
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 Apr 2026 22:40
- Source
- TipRanks
Black Hawk Acquisition Faces Nasdaq Listing Compliance Challenge
Black Hawk Acquisition Corporation (BKHA) has received a notice from Nasdaq due to failing to meet the $50 million market value of listed securities requirement for the past 30 consecutive business days. The company has until September 28, 2026, to regain compliance. Failure to c
- Tone
- Negative 18/100
- Event
- Deals and strategy
- Published
- 01 Apr 2026 22:10
- Source
- TipRanks
Black Hawk Acquisition receives Nasdaq notice for market value non-compliance
Black Hawk Acquisition Corp (BKHAU) has received a Nasdaq notice for non-compliance, as its market value has fallen below the required $50 million minimum for continued listing. The company has 180 calendar days to regain compliance by having its market value close at or above $5
- Tone
- Negative 30/100
- Event
- Deals and strategy
- Published
- 01 Apr 2026 21:10
- Source
- Investing.com Canada
Black Hawk Acquisition (NASDAQ: BKHA) faces Nasdaq warning over $50M market value rule
Black Hawk Acquisition Corporation (NASDAQ: BKHA) has received a warning from Nasdaq for failing to meet the minimum $50 million market value of listed securities requirement for the Nasdaq Global Market. The company has 180 calendar days, until September 28, 2026, to regain comp
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Apr 2026 21:10
- Source
- Stock Titan
Black Hawk’s Vesicor Target Appoints New Chief Executive
Vesicor Therapeutics, the de-SPAC target of Black Hawk Acquisition Corporation (BKHA), has appointed Michael Tolentino, M.D., as its new chief executive officer. Dr. Tolentino, a veteran biotech executive and retinal surgeon known for his work in anti-VEGF drug discovery, will le
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 20 Mar 2026 20:10
- Source
- The Globe and Mail
Black Hawk Acquisition (Nasdaq: BKHA) spotlights Vesicor CEO hire
Black Hawk Acquisition (Nasdaq: BKHA) announced that its proposed de-SPAC business combination target, Vesicor Therapeutics, has appointed Michael Tolentino, M.D. as Chief Executive Officer, effective March 17, 2026. Founder Luo Feng, Ph.D. will transition to Chief Scientific Off
- Tone
- Positive 67/100
- Event
- Deals and strategy
- Published
- 17 Mar 2026 21:40
- Source
- Stock Titan
Black Hawk Acquisition Delays Annual 10-K Filing
Black Hawk Acquisition Corporation (BKHA) announced a delay in filing its annual Form 10-K for the fiscal year ending November 30, 2025. The company, a smaller reporting entity, cited the need for additional time to complete financial statements. They expect to file within 15 cal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 Mar 2026 02:09
- Source
- The Globe and Mail
Black Hawk merger target Vesicor overhauls leadership team
Vesicor Therapeutics, Inc., a proposed merger target for Black Hawk Acquisition Corporation Class A (BKHA), has announced significant leadership changes. This follows the unexpected death of its CFO, Michael Bowen, leading to the immediate appointment of Mitchell Creem as the new
- Tone
- Positive 67/100
- Event
- Deals and strategy
- Published
- 23 Feb 2026 04:09
- Source
- The Globe and Mail
Black Hawk Acquisition Announces Sponsor-Backed Convertible Note Financing
Black Hawk Acquisition Corporation (BKHA) has announced a sponsor-backed convertible note financing of up to $300,000 from Black Hawk Management LLC to cover working capital needs. The note bears 10% annual interest and matures upon the initial business combination or liquidation
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Feb 2026 20:32
- Source
- TipRanks
Black Hawk Acquisition reports changes at Vesicor Therapeutics following executive death
Black Hawk Acquisition Corp announced leadership changes at its proposed business combination target, Vesicor Therapeutics, following the death of Vesicor's CFO, Michael Bowen. Mitchell Creem was appointed the new CFO and Frederick Woodruff Field was appointed as a director. Thes
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 04 Feb 2026 10:59
- Source
- Investing.com UK
Black Hawk Acquisition says on Jan 27 Vesicor CFO Michael Bowen passes away
Black Hawk Acquisition Corporation announced on February 3, 2026, that Michael Bowen, the Chief Financial Officer of Vesicor, passed away on January 27. This news comes after previous announcements regarding a business combination agreement between Vesicor Therapeutics and Black
- Tone
- Negative 32/100
- Event
- Deals and strategy
- Published
- 03 Feb 2026 18:28
- Source
- marketscreener.com
BKHAR SEC Filings
This page provides a comprehensive resource for Black Hawk Acquisition (BKHAR) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading disclosures. It offers AI-powered analysis with summaries, sentiment, and impact scores, alongside end-of-day stock performance data. A
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Jan 2026 12:58
- Source
- Stock Titan
Black Hawk Acquisition Corporation (NASDAQ:BKHA) Short Interest Down 50.0% in September
Black Hawk Acquisition Corporation (NASDAQ:BKHA) experienced a significant 50.0% decrease in short interest in September, dropping from 200 shares to 100 shares. Despite this, several institutional investors have increased their stakes, while analysts maintain a "sell" rating on
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Oct 2025 00:00
- Source
- MarketBeat
Black Hawk Acquisition Delays 10-Q Filing - TipRanks
Black Hawk Acquisition Corporation Class A announced a delay in filing its Form 10-Q for the financial period ending August 31, 2025, due to difficulties in compiling financial information. The company expects to file within the extension period and anticipates no significant fin
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Oct 2025 12:41
- Source
- TipRanks
BKHAU|Black Hawk Acquisition Corp|Price:14.500|Chg%:0.75
Black Hawk Acquisition Corp (BKHAU) is currently trading at $14.50, reflecting a 5.45% increase. The company is a blank check company formed for the purpose of a business combination, with no specific targets currently under consideration, and has not yet generated any revenues.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Sep 2025 15:09
- Source
- TradingKey
Black Hawk Acquisition Corporation (BKHA) Company Information
This article provides key company information for Black Hawk Acquisition Corporation (BKHA), including its exchange listings, industry, sector, market capitalization, and shares outstanding. It details the data sources and the analytical model used by Simply Wall St for its repor
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 May 2024 02:09
- Source
- Simply Wall Street
Black Hawk Acquisition Corporation Rings the Nasdaq Stock Market Opening Bell
Black Hawk Acquisition Corporation (Nasdaq: BKHAU), a Cayman Islands SPAC, celebrated by ringing the Opening Bell at the Nasdaq MarketSite in Times Square. Kent Kaufman, CEO, had the honor of ringing the bell to commemorate the occasion. This event is part of the March 2024 Nasda
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 Mar 2024 00:00
- Source
- Nasdaq